Malignant fibrous histiocytoma epidemiology and demographics: Difference between revisions
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Malignant fibrous histiocytoma}} | {{Malignant fibrous histiocytoma}} | ||
{{CMG}};{{AE}} {{NM}} | {{CMG}};{{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | |||
===Prevalence=== | |||
===Incidence=== | |||
===Age=== | |||
Myelodysplastic syndrome commonly affects individuals between 32-80 (mean 59 years) years of age.<ref name=radiopaedia>Malignant fibrous histiocytoma. Dr Henry Knipe and A.Prof Frank Gaillard et al. Radiopaedia (2015). http://radiopaedia.org/articles/malignant-fibrous-histiocytoma. Accessed on December 17, 2015</ref> | |||
===Gender=== | |||
Males are more commonly affected with myelodysplastic syndrome than females. The male to female ratio is 1.2:1.<ref name=radiopaedia>Malignant fibrous histiocytoma. Dr Henry Knipe and A.Prof Frank Gaillard et al. Radiopaedia (2015). http://radiopaedia.org/articles/malignant-fibrous-histiocytoma. Accessed on December 17, 2015</ref> | |||
===Race=== | |||
==References== | ==References== | ||
{{reflist| | {{reflist|1}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Latest revision as of 19:09, 17 December 2015
|
Malignant fibrous histiocytoma Microchapters |
|
Differentiating Malignant Fibrous Histiocytoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Malignant fibrous histiocytoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Malignant fibrous histiocytoma epidemiology and demographics |
|
FDA on Malignant fibrous histiocytoma epidemiology and demographics |
|
CDC on Malignant fibrous histiocytoma epidemiology and demographics |
|
Malignant fibrous histiocytoma epidemiology and demographics in the news |
|
Blogs on Malignant fibrous histiocytoma epidemiology and demographics |
|
Directions to Hospitals Treating Malignant fibrous histiocytoma |
|
Risk calculators and risk factors for Malignant fibrous histiocytoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Epidemiology and Demographics
Prevalence
Incidence
Age
Myelodysplastic syndrome commonly affects individuals between 32-80 (mean 59 years) years of age.[1]
Gender
Males are more commonly affected with myelodysplastic syndrome than females. The male to female ratio is 1.2:1.[1]
Race
References
- ↑ 1.0 1.1 Malignant fibrous histiocytoma. Dr Henry Knipe and A.Prof Frank Gaillard et al. Radiopaedia (2015). http://radiopaedia.org/articles/malignant-fibrous-histiocytoma. Accessed on December 17, 2015